TLX
TELIXPHARM FPO [TLX]
Healthcare · ASX Small Cap
$9.7400 -2.6%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +3First seen: 2026-02-25
Score Breakdown
Technical47
Catalyst50
Sentiment50
Fundamental97
Momentum44
Risk Gate40
Active Signals
Bullish Signals
- VPT accumulation divergence (bullish)
- Strong cash runway (33 quarters)
- Low P/S ratio (4.2x)
- Strong revenue growth (+49%)
- EPS estimates revised upward (+10pts)
- Near 52-week low (8% of range)
- Very high short interest (12.7%)
- CANSLIM A: Turned profitable
- CANSLIM I: Institutional ownership (21%)
- Severe 12-1 momentum decline (-64%)
- Poor risk-adjusted momentum (Sharpe -1.9)
- Earnings momentum: 2 consecutive improvements
- Strong revenue momentum (+49%)
- Analyst EPS expectations rising (+109%)
- Days to cover very high (13.8)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Stochastic bearish crossover (from high)
- Below 200-day MA (long-term downtrend)
- Negative profit margins (-1%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Appendix 4G and 2025 Corporate Governance Statement
NONE 2025 Full Year Results Presentation
NONE 2025 Full Year Results Announcement
LOW Appendix 4E and 2025 Annual Report
Recent ASX Announcements
| 2026-02-19 | Appendix 4G and 2025 Corporate Governance Statement |
| 2026-02-19 | 2025 Full Year Results Presentation PRICE SENSITIVE |
| 2026-02-19 | 2025 Full Year Results Announcement PRICE SENSITIVE |
| 2026-02-19 | Appendix 4E and 2025 Annual Report PRICE SENSITIVE |
| 2026-02-19 | Change in substantial holding |
Key Metrics
$3.3B
Market Cap
3.1M
Avg Volume
0.9x
Vol Ratio
$8.26 — $29.72
52-Week Range
12.7%
Short Interest
N/A
Cash Runway
-1.9%
ROE
-0.9%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | neutral | EPS Growth: 0% |
| A | Annual Earnings | improving | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 81% |
| L | Leader vs Laggard | laggard | RS: -6 |
| I | Institutional Sponsorship | pass | Inst: 21% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #25 of 119 · Sector avg: 51
View all Healthcare signals →